HealthGovernment Caps Trade Margin on Cancer Drugs at 30% to Cut Costs
The Indian government has capped trade margins on non-scheduled anti-cancer drugs at 30% of the maximum retail price (MRP). This move aims to reduce cancer drug costs by up to 70%. The decision follows Supreme Court scrutiny over the price gap of cancer medicines, intending to make treatments more affordable for patients across India.
India Today·

